Literature DB >> 30327316

Pregabalin and gabapentin become controlled drugs to cut deaths from misuse.

Susan Mayor1.   

Abstract

Entities:  

Year:  2018        PMID： 30327316     DOI： 10.1136/bmj.k4364

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Patterns of pregabalin initiation and discontinuation after its subsidy in Australia.

Authors:  Tricia Chiu; Jonathan Brett; Sallie-Anne Pearson; Andrea L Schaffer
Journal:  Br J Clin Pharmacol       Date:  2020-03-22       Impact factor: 4.335

2.  Often Off-label: Questionable Gabapentinoid Use Noted at Hospital Admission Warrants Deprescribing.

Authors:  Kenneth Lam; Paula A Rochon; Michael A Steinman
Journal:  J Hosp Med       Date:  2019-09       Impact factor: 2.960

3.  Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden.

Authors:  Yasmina Molero; Henrik Larsson; Brian M D'Onofrio; David J Sharp; Seena Fazel
Journal:  BMJ       Date:  2019-06-12

4.  The effects of pregabalin, solifenacin and their combination therapy on ureteral double-J stent-related symptoms: A randomized controlled clinical trial.

Authors:  Siavash Falahatkar; Mohammadreza Beigzadeh; Gholamreza Mokhtari; Samaneh Esmaeili; Ehsan Kazemnezhad; Atiyeh Amin; Nadia Rastjou Herfeh; Reza Falahatkar
Journal:  Int Braz J Urol       Date:  2021 May-Jun       Impact factor: 1.541

5.  Pregabalin abuse and dependence during insomnia and protocol for short-term withdrawal management with diazepam: examples from case reports.

Authors:  Basavaraja Papanna; Carlo Lazzari; Kapil Kulkarni; Sivasankar Perumal; Abdul Nusair
Journal:  Sleep Sci       Date:  2021 Apr-Jun

6.  Antidepressant and anticonvulsant prescription rates in patients with osteoarthritis: a population-based cohort study.

Authors:  Jacoline J van den Driest; Dieuwke Schiphof; Marcel de Wilde; Patrick J E Bindels; Johan van der Lei; Sita M A Bierma-Zeinstra
Journal:  Rheumatology (Oxford)       Date:  2021-05-14       Impact factor: 7.580
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.